Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company.
A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Navan Inc Ordinary Shares | Benjamin A. Horowitz | Director, Ten Percent Owner | 31 Oct 2025 | 31,226,580 | 0 | - | - | Series C Preferred Stock | ||
| Navan Inc Ordinary Shares | Benjamin A. Horowitz | Director, Ten Percent Owner | 31 Oct 2025 | 20,244,280 | 0 | - | - | Series D Preferred Stock | ||
| Navan Inc Ordinary Shares | Oren Zeev | Director, Ten Percent Owner | 31 Oct 2025 | 15,766,767 | 15,766,767 | - | - | Class A Common Stock | ||
| Navan Inc Ordinary Shares | Benjamin A. Horowitz | Director, Ten Percent Owner | 31 Oct 2025 | 10,408,860 | 10,408,860 | - | - | Class A Common Stock | ||
| Navan Inc Ordinary Shares | Benjamin A. Horowitz | Director, Ten Percent Owner | 31 Oct 2025 | 9,763,156 | 0 | - | - | Series E Preferred Stock | ||
| Navan Inc Ordinary Shares | Oren Zeev | Director, Ten Percent Owner | 31 Oct 2025 | 9,114,792 | 10,823,032 | - | - | Class A Common Stock | ||
| Navan Inc Ordinary Shares | Oren Zeev | Director, Ten Percent Owner | 31 Oct 2025 | 9,114,792 | 0 | - | - | Series B Preferred Stock | ||
| Navan Inc Ordinary Shares | Ilan Twig | Director, Chief Technology Officer, Ten Percent Owner | 31 Oct 2025 | 8,939,081 | 0 | - | 0 | Class A Common Stock | ||
| Navan Inc Ordinary Shares | Ilan Twig | Director, Chief Technology Officer, Ten Percent Owner | 31 Oct 2025 | 8,939,081 | 8,939,081 | - | - | Class B Common Stock | ||
| Navan Inc Ordinary Shares | Sandesh Patnam | Director | 31 Oct 2025 | 8,010,958 | 0 | - | - | Series G-1 Preferred Stock | ||
| Navan Inc Ordinary Shares | Oren Zeev | Director, Ten Percent Owner | 31 Oct 2025 | 7,347,850 | 0 | - | - | Series A Preferred Stock | ||
| Navan Inc Ordinary Shares | Arif Janmohamed | Director | 31 Oct 2025 | 7,287,940 | 0 | - | - | Series D Preferred Stock | ||
| Navan Inc Ordinary Shares | Oren Zeev | Director, Ten Percent Owner | 31 Oct 2025 | 7,024,053 | 0 | - | - | Series A-1 Preferred Stock | ||
| Navan Inc Ordinary Shares | Benjamin A. Horowitz | Director, Ten Percent Owner | 31 Oct 2025 | 6,757,090 | 6,757,090 | - | - | Class A Common Stock | ||
| Navan Inc Ordinary Shares | Benjamin A. Horowitz | Director, Ten Percent Owner | 31 Oct 2025 | 6,245,316 | 0 | - | - | Series C Preferred Stock | ||
| Navan Inc Ordinary Shares | Arif Janmohamed | Director | 31 Oct 2025 | 5,249,132 | 0 | - | - | Series E Preferred Stock | ||
| Navan Inc Ordinary Shares | Sandesh Patnam | Director | 31 Oct 2025 | 5,089,572 | 5,089,572 | - | 21.3 | 108,153,405 | Class A Common Stock | |
| Navan Inc Ordinary Shares | Oren Zeev | Director, Ten Percent Owner | 31 Oct 2025 | 4,529,493 | 0 | - | - | Series A Preferred Stock | ||
| Navan Inc Ordinary Shares | Oren Zeev | Director, Ten Percent Owner | 31 Oct 2025 | 4,529,493 | 4,529,493 | - | - | Class A Common Stock | ||
| Navan Inc Ordinary Shares | Arif Janmohamed | Director | 31 Oct 2025 | 4,478,486 | 4,780,989 | - | - | Class A Common Stock | ||
| Beyond Meat Inc | Ethan Brown | President, Chief Exec. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2025 | 4,416,616 | 6,043,834 (9%) | 7% | 0 | Common Stock | |
| Navan Inc Ordinary Shares | Benjamin A. Horowitz | Director, Ten Percent Owner | 31 Oct 2025 | 4,305,906 | 5,574,551 | - | - | Class A Common Stock | ||
| Navan Inc Ordinary Shares | Ariel M. Cohen | Director, Chairperson and CEO, Ten Percent Owner | 31 Oct 2025 | 3,165,756 | 0 | - | 0 | Class A Common Stock | ||
| Navan Inc Ordinary Shares | Ariel M. Cohen | Director, Chairperson and CEO, Ten Percent Owner | 31 Oct 2025 | 3,165,756 | 3,165,756 | - | - | Class B Common Stock | ||
| Navan Inc Ordinary Shares | Sandesh Patnam | Director | 31 Oct 2025 | 2,705,707 | 2,705,707 | - | - | Class A Common Stock | ||
| Navan Inc Ordinary Shares | Benjamin A. Horowitz | Director, Ten Percent Owner | 31 Oct 2025 | 2,309,297 | 0 | - | - | Series F Preferred Stock | ||
| Navan Inc Ordinary Shares | Benjamin A. Horowitz | Director, Ten Percent Owner | 31 Oct 2025 | 2,081,772 | 2,081,772 | - | - | Class A Common Stock | ||
| Navan Inc Ordinary Shares | Oren Zeev | Director, Ten Percent Owner | 31 Oct 2025 | 1,974,957 | 1,974,957 | - | - | Class A Common Stock | ||
| Navan Inc Ordinary Shares | Oren Zeev | Director, Ten Percent Owner | 31 Oct 2025 | 1,974,957 | 0 | - | - | Series C Preferred Stock | ||
| Clarivate PLC | Andrew M. Snyder | Director | Purchase of securities on an exchange or from another person at price $ 3.33 per share. | 31 Oct 2025 | 1,460,000 | 2,247,510 | - | 3.3 | 4,861,800 | Ordinary Shares |
| Navan Inc Ordinary Shares | Oren Zeev | Director, Ten Percent Owner | 31 Oct 2025 | 1,394,864 | 0 | - | - | Series B Preferred Stock | ||
| Bakkt Holdings Inc (Class A) | Akshay Naheta | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2025 | 1,342,282 | 1,342,282 | - | - | Stock Option (right to buy) | |
| Accuray Inc | Stephen R. LaNeve | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2025 | 1,250,000 | 1,250,000 | - | - | Performance Stock Units | |
| Accuray Inc | Stephen R. LaNeve | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2025 | 1,250,000 | 1,250,000 | - | - | Restricted Stock Units | |
| Navan Inc Ordinary Shares | Benjamin A. Horowitz | Director, Ten Percent Owner | 31 Oct 2025 | 1,201,643 | 0 | - | - | Series G-1 Preferred Stock | ||
| Navan Inc Ordinary Shares | Arif Janmohamed | Director | 31 Oct 2025 | 1,148,606 | 0 | - | - | Series E Preferred Stock | ||
| Navan Inc Ordinary Shares | Oren Zeev | Director, Ten Percent Owner | 31 Oct 2025 | 1,000,915 | 1,000,915 | - | - | Class A Common Stock | ||
| Navan Inc Ordinary Shares | Ilan Twig | Director, Chief Technology Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 25.00 per share. | 31 Oct 2025 | 1,000,000 | 8,939,081 | - | 25 | 25,000,000 | Class A Common Stock |
| Applied Digital Corp | Wesley Cummins | Director, CEO; Chairman | Other type of transaction at price $ 0.00 per share. | 31 Oct 2025 | 903,970 | 722,483 | - | - | Common Stock | |
| Navan Inc Ordinary Shares | Oren Zeev | Director, Ten Percent Owner | 31 Oct 2025 | 900,944 | 0 | - | - | Series D Preferred Stock | ||
| Navan Inc Ordinary Shares | Oren Zeev | Director, Ten Percent Owner | 31 Oct 2025 | 857,010 | 917,394 | - | - | Class A Common Stock | ||
| Navan Inc Ordinary Shares | Oren Zeev | Director, Ten Percent Owner | 31 Oct 2025 | 836,401 | 1,124,268 | - | - | Class A Common Stock | ||
| Navan Inc Ordinary Shares | Ariel M. Cohen | Director, Chairperson and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 25.00 per share. | 31 Oct 2025 | 833,333 | 3,165,756 | - | 25 | 20,833,325 | Class A Common Stock |
| Beyond Meat Inc | Lubi Kutua | CFO, Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2025 | 806,033 | 979,002 (1%) | 1% | 0 | Common Stock | |
| Navan Inc Ordinary Shares | Sandesh Patnam | Director | 31 Oct 2025 | 784,685 | 5,874,257 | - | 0.0 | 23,541 | Class A Common Stock | |
| Navan Inc Ordinary Shares | Sandesh Patnam | Director | 31 Oct 2025 | 784,685 | 0 | - | - | Warrant (Right to Buy) | ||
| Navan Inc Ordinary Shares | Oren Zeev | Director, Ten Percent Owner | 31 Oct 2025 | 770,077 | 770,077 | - | - | Class A Common Stock | ||
| Navan Inc Ordinary Shares | Oren Zeev | Director, Ten Percent Owner | 31 Oct 2025 | 770,077 | 0 | - | - | Series E Preferred Stock | ||
| Navan Inc Ordinary Shares | Ilan Twig | Director, Chief Technology Officer, Ten Percent Owner | 31 Oct 2025 | 766,666 | 0 | - | 0 | Class A Common Stock | ||
| Navan Inc Ordinary Shares | Ilan Twig | Director, Chief Technology Officer, Ten Percent Owner | 31 Oct 2025 | 766,666 | 766,666 | - | - | Class B Common Stock | ||
| Navan Inc Ordinary Shares | Benjamin A. Horowitz | Director, Ten Percent Owner | 31 Oct 2025 | 765,736 | 0 | - | - | Series Seed Preferred Stock | ||
| Navan Inc Ordinary Shares | Ariel M. Cohen | Director, Chairperson and CEO, Ten Percent Owner | 31 Oct 2025 | 763,653 | 0 | - | 0 | Class A Common Stock | ||
| Navan Inc Ordinary Shares | Ariel M. Cohen | Director, Chairperson and CEO, Ten Percent Owner | 31 Oct 2025 | 763,653 | 0 | - | 0 | Class A Common Stock | ||
| Navan Inc Ordinary Shares | Ariel M. Cohen | Director, Chairperson and CEO, Ten Percent Owner | 31 Oct 2025 | 763,653 | 763,653 | - | - | Class B Common Stock | ||
| Navan Inc Ordinary Shares | Ariel M. Cohen | Director, Chairperson and CEO, Ten Percent Owner | 31 Oct 2025 | 763,653 | 763,653 | - | - | Class B Common Stock | ||
| Navan Inc Ordinary Shares | Ariel M. Cohen | Director, Chairperson and CEO, Ten Percent Owner | 31 Oct 2025 | 763,653 | 763,653 | - | - | Class B Common Stock | ||
| Navan Inc Ordinary Shares | Ariel M. Cohen | Director, Chairperson and CEO, Ten Percent Owner | 31 Oct 2025 | 763,653 | 0 | - | 0 | Class A Common Stock | ||
| Navan Inc Ordinary Shares | Arif Janmohamed | Director | 31 Oct 2025 | 649,200 | 0 | - | - | Series F Preferred Stock | ||
| Meta | Mark Zuckerberg | Director, COB and CEO, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Oct 2025 | 639,347 | 639,347 (0%) | 0% | 0 | Class A Common Stock | |
| Navan Inc Ordinary Shares | Oren Zeev | Director, Ten Percent Owner | 31 Oct 2025 | 624,764 | 0 | - | - | Series F Preferred Stock | ||
| Navan Inc Ordinary Shares | Benjamin A. Horowitz | Director, Ten Percent Owner | 31 Oct 2025 | 607,161 | 607,161 | - | - | Class A Common Stock | ||
| Navan Inc Ordinary Shares | Benjamin A. Horowitz | Director, Ten Percent Owner | 31 Oct 2025 | 603,920 | 0 | - | - | Series A Preferred Stock | ||
| Navan Inc Ordinary Shares | Arif Janmohamed | Director | 31 Oct 2025 | 600,821 | 0 | - | - | Series G-1 Preferred Stock | ||
| Navan Inc Ordinary Shares | Arif Janmohamed | Director | 31 Oct 2025 | 587,965 | 587,965 | - | - | Class A Common Stock | ||
| Beyond Meat Inc | Teri L. Witteman | Chief Legal Officer, Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2025 | 552,077 | 654,223 (1%) | 0% | 0 | Common Stock | |
| Beyond Meat Inc | Dariush Ajami | Chief Innovation Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2025 | 552,077 | 731,872 (1%) | 0% | 0 | Common Stock | |
| Clarivate PLC | Kenneth Cornick | Director | Purchase of securities on an exchange or from another person at price $ 3.38 per share. | 31 Oct 2025 | 500,000 | 775,000 | - | 3.4 | 1,690,000 | Ordinary Shares |
| Navan Inc Ordinary Shares | Oren Zeev | Director, Ten Percent Owner | 31 Oct 2025 | 481,298 | 0 | - | - | Series E Preferred Stock | ||
| Las Vegas Sands | Robert Glen Goldstein | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 34.28 per share. | 31 Oct 2025 | 400,000 | 400,000 (0%) | 0% | 34.3 | 13,712,000 | Common Stock |
| Las Vegas Sands | Robert Glen Goldstein | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Oct 2025 | 400,000 | 400,000 | - | - | Option (Right to Buy) | |
| Las Vegas Sands | Robert Glen Goldstein | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 59.20 per share. | 31 Oct 2025 | 400,000 | 0 (0%) | 0% | 59.2 | 23,680,000 | Common Stock |
| Meta | Mark Zuckerberg | Director, COB and CEO, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Oct 2025 | 397,007 | 0 (0%) | 0% | 0 | Class A Common Stock | |
| Navan Inc Ordinary Shares | Oren Zeev | Director, Ten Percent Owner | 31 Oct 2025 | 382,900 | 382,900 | - | - | Class A Common Stock | ||
| Navan Inc Ordinary Shares | Oren Zeev | Director, Ten Percent Owner | 31 Oct 2025 | 382,900 | 0 | - | - | Series D Preferred Stock | ||
| Navan Inc Ordinary Shares | Oren Zeev | Director, Ten Percent Owner | 31 Oct 2025 | 355,103 | 0 | - | - | Series Seed Preferred Stock | ||
| Accuray Inc | Steven F. Mayer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2025 | 354,609 | 354,609 (0%) | 0% | 0 | Common Stock | |
| Danaher | Mitchell P. Rales | Director, Chairman of Exec. Committee | Sale of securities on an exchange or to another person at price $ 215.67 per share. | 31 Oct 2025 | 308,423 | 1,281,805 (0%) | 0% | 215.7 | 66,517,588 | Common Stock, par value $.01 |
| QuantumScape Corp (Class A) | Brad W. Buss | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.23 per share. | 31 Oct 2025 | 300,000 | 422,476 | - | 6.2 | 1,870,080 | Class A Common Stock |
| QuantumScape Corp (Class A) | Brad W. Buss | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Oct 2025 | 300,000 | 707,612 | - | - | Stock Option (Right to Buy) | |
| Marker Therapeutics Inc | Juan Vera | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2025 | 250,000 | 250,000 | - | - | Employee Stock Option (right to buy) | |
| Meta | Mark Zuckerberg | Director, COB and CEO, Ten Percent Owner | 31 Oct 2025 | 242,340 | 242,340 (0%) | 0% | 0 | Class A Common Stock | ||
| Meta | Mark Zuckerberg | Director, COB and CEO, Ten Percent Owner | 31 Oct 2025 | 242,340 | 109,373,980 | - | - | Class B Common Stock | ||
| Meta | Mark Zuckerberg | Director, COB and CEO, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Oct 2025 | 242,340 | 0 (0%) | 0% | 0 | Class A Common Stock | |
| Navan Inc Ordinary Shares | Michael Sindicich | President | Sale of securities on an exchange or to another person at price $ 25.00 per share. | 31 Oct 2025 | 231,842 | 319,863 | - | 25 | 5,796,050 | Class A Common Stock |
| Clarivate PLC | Kenneth Cornick | Director | Purchase of securities on an exchange or from another person at price $ 3.52 per share. | 31 Oct 2025 | 225,000 | 1,000,000 | - | 3.5 | 792,000 | Ordinary Shares |
| AMEX | Stephen J. Squeri | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2025 | 224,551 | 224,551 | - | - | Employee Stock Option (Right to Buy) | |
| Danaher | Mitchell P. Rales | Director, Chairman of Exec. Committee | Sale of securities on an exchange or to another person at price $ 216.26 per share. | 31 Oct 2025 | 223,449 | 1,058,356 (0%) | 0% | 216.3 | 48,323,081 | Common Stock, par value $.01 |
| Warner Bros. (Class A) | Gunnar Wiedenfels | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 22.50 per share. | 31 Oct 2025 | 222,210 | 918,940 (0%) | 0% | 22.5 | 4,999,725 | Series A Common Stock |
| StableX Tech Inc | Joshua Nathaniel Silverman | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2025 | 220,513 | 220,513 | - | - | Employee Stock Option (Right to Buy | |
| Strata Critical Medical Inc (Class A) | Melissa M. Tomkiel | Director, Co-CEO and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2025 | 208,929 | 1,479,301 | - | 0 | Class A common stock, $0.0001 par value per share | |
| Navan Inc Ordinary Shares | Arif Janmohamed | Director | 31 Oct 2025 | 200,273 | 0 | - | - | Series G-1 Preferred Stock | ||
| DuPont de Nemours | Edward D. Breen | Director, Executive Chair | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2025 | 192,332 | 330,350 (0%) | 0% | 0 | Common Stock | |
| Navan Inc Ordinary Shares | Michael Sindicich | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Oct 2025 | 182,084 | 71,249 | - | - | Stock Option (Right to Buy) | |
| Navan Inc Ordinary Shares | Michael Sindicich | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.05 per share. | 31 Oct 2025 | 182,084 | 551,705 | - | 10.0 | 1,829,944 | Class A Common Stock |
| Strata Critical Medical Inc (Class A) | William A. Heyburn | Director, Co-CEO and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2025 | 181,072 | 1,486,569 | - | 0 | Class A common stock, $0.0001 par value per share | |
| QuantumScape Corp (Class A) | Brad W. Buss | Director | Sale of securities on an exchange or to another person at price $ 18.41 per share. | 31 Oct 2025 | 175,000 | 122,476 | - | 18.4 | 3,221,768 | Class A Common Stock |
| Invesco Ltd | Douglas J. Sharp | Senior Managing Director | Sale of securities on an exchange or to another person at price $ 23.56 per share. | 31 Oct 2025 | 160,000 | 192 (0%) | 0% | 23.6 | 3,768,832 | Common Shares |
| Opko Health Inc | Phillip Frost | Director, CEO & Chairman, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 1.42 per share. | 31 Oct 2025 | 150,000 | 214,386,448 (32%) | 0% | 1.4 | 213,435 | Common Stock |
| Marker Therapeutics Inc | Kathryn Penkus Corzo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2025 | 147,611 | 147,611 | - | - | Stock Option (Right to Buy) | |
| Navan Inc Ordinary Shares | Oren Zeev | Director, Ten Percent Owner | 31 Oct 2025 | 135,284 | 0 | - | - | Series G-1 Preferred Stock | ||
| Bakkt Holdings Inc (Class A) | Marc D’Annunzio | General Counsel & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2025 | 134,228 | 134,228 | - | - | Stock Option (right to buy) | |
| Clover Health Investments Corp (Class A) | Karen M. Soares | General Counsel & Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.53 per share. | 31 Oct 2025 | 131,521 | 1,274,314 | - | 3.5 | 464,269 | Class A Common Stock |
| Navan Inc Ordinary Shares | Ilan Twig | Director, Chief Technology Officer, Ten Percent Owner | 31 Oct 2025 | 127,846 | 0 | - | 0 | Class A Common Stock | ||
| Navan Inc Ordinary Shares | Ilan Twig | Director, Chief Technology Officer, Ten Percent Owner | 31 Oct 2025 | 127,846 | 127,846 | - | - | Class B Common Stock | ||
| QuantumScape Corp (Class A) | Brad W. Buss | Director | Sale of securities on an exchange or to another person at price $ 17.37 per share. | 31 Oct 2025 | 125,000 | 297,476 | - | 17.4 | 2,170,813 | Class A Common Stock |
| Roku Inc (Class A) | Charles Collier | President, Roku Media | Exercise or conversion of derivative security received from the company (such as an option) at price $ 49.59 per share. | 31 Oct 2025 | 118,088 | 118,288 (0%) | 0% | 49.6 | 5,855,984 | Class A Common Stock |
| Roku Inc (Class A) | Charles Collier | President, Roku Media | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Oct 2025 | 118,088 | 513,446 | - | - | Employee Stock Option (right to buy) | |
| Roku Inc (Class A) | Charles Collier | President, Roku Media | Sale of securities on an exchange or to another person at price $ 115.00 per share. | 31 Oct 2025 | 118,088 | 200 (0%) | 0% | 115 | 13,580,120 | Class A Common Stock |
| Sky Quarry Inc | David Sealock | Former CEO | Sale of securities on an exchange or to another person at price $ 0.45 per share. | 31 Oct 2025 | 109,698 | 535,977 | - | 0.4 | 49,364 | Common Shares |
| Strata Critical Medical Inc (Class A) | Melissa M. Tomkiel | Director, Co-CEO and General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.03 per share. | 31 Oct 2025 | 106,659 | 1,372,642 | - | 5.0 | 536,495 | Class A common stock, $0.0001 par value per share |
| Clover Health Investments Corp (Class A) | Jamie L. Reynoso | CEO, Medicare Advantage | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.53 per share. | 31 Oct 2025 | 101,917 | 2,853,309 | - | 3.5 | 359,767 | Class A Common Stock |
| Strata Critical Medical Inc (Class A) | William A. Heyburn | Director, Co-CEO and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.03 per share. | 31 Oct 2025 | 100,133 | 1,386,436 | - | 5.0 | 503,669 | Class A common stock, $0.0001 par value per share |
| Alphatec Holdings Inc | Craig E. Hunsaker | EVP, PEOPLE & CULTURE | Sale of securities on an exchange or to another person at price $ 19.95 per share. | 31 Oct 2025 | 100,000 | 1,289,142 (2%) | 0% | 20.0 | 1,995,000 | Common Stock |
| Morgan Stanley | Edward N. Pick | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 164.34 per share. | 31 Oct 2025 | 100,000 | 574,986 (0%) | 0% | 164.3 | 16,434,440 | Common Stock |
| Navan Inc Ordinary Shares | Oren Zeev | Director, Ten Percent Owner | 31 Oct 2025 | 99,971 | 0 | - | - | Series Seed Preferred Stock | ||
| DuPont de Nemours | Lori D. Koch | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2025 | 98,613 | 288,325 (0%) | 0% | 0 | Common Stock | |
| Knowles Corp | Jeffrey S. Niew | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.07 per share. | 31 Oct 2025 | 98,252 | 1,037,622 (1%) | 0% | 16.1 | 1,578,910 | Common Stock |
| Knowles Corp | Jeffrey S. Niew | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Oct 2025 | 98,252 | 38,404 | - | - | Non-Qualified Stock Option (right to buy) | |
| Knowles Corp | Jeffrey S. Niew | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 23.71 per share. | 31 Oct 2025 | 98,252 | 939,370 (1%) | 0% | 23.7 | 2,330,027 | Common Stock |
| Navan Inc Ordinary Shares | Oren Zeev | Director, Ten Percent Owner | 31 Oct 2025 | 96,962 | 0 | - | - | Series Seed Preferred Stock | ||
| Clover Health Investments Corp (Class A) | Conard Wai | CEO, Counterpart Health | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.53 per share. | 31 Oct 2025 | 96,448 | 1,178,015 | - | 3.5 | 340,461 | Class A Common Stock |
| Clover Health Investments Corp (Class A) | Brady Patrick Priest | CEO of Home Care | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.53 per share. | 31 Oct 2025 | 86,610 | 2,253,664 | - | 3.5 | 305,733 | Class A Common Stock |
| Kiniksa Pharma Ltd (Class A) | John F. Paolini | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 37.14 per share. | 31 Oct 2025 | 82,542 | 61,324 (0%) | 0% | 37.1 | 3,065,610 | Class A Ordinary Share |
| Sky Quarry Inc | David Sealock | Former CEO | Sale of securities on an exchange or to another person at price $ 0.46 per share. | 31 Oct 2025 | 81,835 | 645,675 | - | 0.5 | 37,562 | Common Shares |
| AXT Inc | Morris S. Young | CEO | Sale of securities on an exchange or to another person at price $ 8.65 per share. | 31 Oct 2025 | 80,000 | 2,439,490 (6%) | 0% | 8.6 | 691,848 | Common Stock |
| Heico Corp (Class A) | Eric A. Mendelson | Director, Co-COB and Co-CEO, Member of 10% owner group | Exercise or conversion of derivative security received from the company (such as an option) at price $ 44.96 per share. | 31 Oct 2025 | 80,000 | 1,304,411 (2%) | 0% | 45.0 | 3,597,104 | Common Stock |
| Heico Corp (Class A) | Eric A. Mendelson | Director, Co-COB and Co-CEO, Member of 10% owner group | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Oct 2025 | 80,000 | 115,313 | - | - | Option (Right to purchase Common Stock) | |
| Heico Corp (Class A) | Victor H. Mendelson | Director, Co-COB and Co-CEO, Member of 10% owner group | Exercise or conversion of derivative security received from the company (such as an option) at price $ 44.96 per share. | 31 Oct 2025 | 80,000 | 1,314,950 (2%) | 0% | 45.0 | 3,597,104 | Common Stock |
| Heico Corp (Class A) | Victor H. Mendelson | Director, Co-COB and Co-CEO, Member of 10% owner group | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Oct 2025 | 80,000 | 115,313 | - | - | Option (Right to purchase Common Stock) | |
| Bakkt Holdings Inc (Class A) | Akshay Naheta | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 39.34 per share. | 31 Oct 2025 | 69,733 | 261,159 | - | 39.3 | 2,743,296 | Class A Common Stock |
| VF Corp | Martino Scabbia Guerrini | EVP, Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.87 per share. | 31 Oct 2025 | 68,139 | 608,751 (0%) | 0% | 13.9 | 945,088 | Common Stock |
| Danaher | Mitchell P. Rales | Director, Chairman of Exec. Committee | Sale of securities on an exchange or to another person at price $ 217.17 per share. | 31 Oct 2025 | 68,128 | 990,228 (0%) | 0% | 217.2 | 14,795,358 | Common Stock, par value $.01 |
| F5 | Francois Locoh-Donou | Director, President, CEO & Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2025 | 67,620 | 175,173 (0%) | 0% | 0 | Common Stock | |
| AMEX | Anna Marrs | Group Pres., GMNS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2025 | 67,365 | 67,365 | - | - | Employee Stock Option (Right to Buy) | |
| AMEX | Raymond Donald Joabar | Grp. Pres., Global Comm. Serv. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2025 | 67,365 | 67,365 | - | - | Employee Stock Option (Right to Buy) | |
| HCA Healthcare | Samuel N. Hazen | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 69.58 per share. | 31 Oct 2025 | 58,050 | 75,279 (0%) | 0% | 69.6 | 4,039,119 | Common Stock |
| HCA Healthcare | Samuel N. Hazen | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Oct 2025 | 58,050 | 0 | - | - | Stock Appreciation Right | |
| Navan Inc Ordinary Shares | Oren Zeev | Director, Ten Percent Owner | 31 Oct 2025 | 57,264 | 0 | - | - | Series Seed Preferred Stock | ||
| Navan Inc Ordinary Shares | Oren Zeev | Director, Ten Percent Owner | 31 Oct 2025 | 57,264 | 57,264 | - | - | Class A Common Stock | ||
| Transocean Ltd | James Roderick Mackenzie | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 3.86 per share. | 31 Oct 2025 | 53,769 | 247,072 (0%) | 0% | 3.9 | 207,548 | Registered Shares |
| Bakkt Holdings Inc (Class A) | Nicholas Baes | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2025 | 53,691 | 53,691 | - | - | Stock Option (right to buy) | |
| AMEX | Laureen E. Seeger | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2025 | 52,395 | 52,395 | - | - | Employee Stock Option (Right to Buy) | |
| AMEX | Denise Pickett | Pres., Enterprise Shared Serv. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2025 | 52,395 | 52,395 | - | - | Employee Stock Option (Right to Buy) | |
| AMEX | Monique Herena | Chief Colleague Exp. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2025 | 52,395 | 52,395 | - | - | Employee Stock Option (Right to Buy) | |
| AMEX | Howard Grosfield | Group Pres., U.S. Cons. Serv. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2025 | 52,395 | 52,395 | - | - | Employee Stock Option (Right to Buy) | |
| Washington Federal Inc | Brent J. Beardall | Director, President & CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Oct 2025 | 50,960 | 299,864 (0%) | 0% | 0 | Common Stock | |
| AMEX | Elizabeth Rutledge | Chief Marketing Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Oct 2025 | 50,000 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| AMEX | Elizabeth Rutledge | Chief Marketing Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 65.43 per share. | 31 Oct 2025 | 50,000 | 135,576 (0%) | 0% | 65.4 | 3,271,500 | Common Stock |
| Insight Molecular Diagnostics Inc | Andrea James | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Oct 2025 | 50,000 | 201,231 (0%) | 0% | 0 | Common Stock | |
| Insight Molecular Diagnostics Inc | Andrea James | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Oct 2025 | 50,000 | 50,000 | - | - | Restricted Stock Units | |
| Insight Molecular Diagnostics Inc | Andrea James | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Oct 2025 | 50,000 | 50,000 | - | - | Restricted Stock Units | |
| Insight Molecular Diagnostics Inc | Andrea James | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Oct 2025 | 50,000 | 201,231 (0%) | 0% | 0 | Common Stock | |
| Navan Inc Ordinary Shares | Michael Sindicich | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Oct 2025 | 49,758 | 0 | - | - | Stock Option (Right to Buy) | |
| Navan Inc Ordinary Shares | Michael Sindicich | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.68 per share. | 31 Oct 2025 | 49,758 | 369,621 | - | 0.7 | 33,960 | Class A Common Stock |
| Hovnanian Enterprises Inc (Class A) | J. Larry Sorsby | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 122.33 per share. | 31 Oct 2025 | 48,311 | 78,269 (1%) | 0% | 122.3 | 5,909,885 | Class A Common Stock |
| Hovnanian Enterprises Inc (Class A) | J. Larry Sorsby | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 122.33 per share. | 31 Oct 2025 | 48,311 | 168,106 (3%) | 0% | 122.3 | 5,909,885 | Class A Common Stock |
| Bakkt Holdings Inc (Class A) | Marc D’Annunzio | General Counsel & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Oct 2025 | 48,188 | 0 | - | - | Bakkt Opco Units | |
| Bakkt Holdings Inc (Class A) | Marc D’Annunzio | General Counsel & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Oct 2025 | 48,188 | 117,436 | - | - | Class A Common Stock | |
| Kiniksa Pharma Ltd (Class A) | John F. Paolini | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.83 per share. | 31 Oct 2025 | 46,000 | 143,866 (0%) | 0% | 8.8 | 406,180 | Class A Ordinary Share |
| Kiniksa Pharma Ltd (Class A) | John F. Paolini | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Oct 2025 | 46,000 | 0 | - | - | Share Option | |
| UiPath Inc (Class A) | Daniel Dines | Director, CEO and Chairman, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 15.72 per share. | 31 Oct 2025 | 45,000 | 29,423,585 | - | 15.7 | 707,270 | Class A Common Stock |
| Portillos Inc Ordinary | Michelle Hook | CFO & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2025 | 43,824 | 217,229 | - | 0 | Class A common stock | |
| Portillos Inc Ordinary | Tony Darden | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2025 | 43,457 | 104,553 | - | 0 | Class A common stock | |
| Strata Critical Medical Inc (Class A) | Amir M. Cohen | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2025 | 41,786 | 141,839 | - | 0 | Class A common stock, $0.0001 par value per share | |
| Navan Inc Ordinary Shares | Benjamin A. Horowitz | Director, Ten Percent Owner | 31 Oct 2025 | 41,635 | 0 | - | - | Series C Preferred Stock | ||
| Marathon Digital Holdings Inc | Frederick G. Thiel | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.76 per share. | 31 Oct 2025 | 40,497 | 3,678,203 (46%) | 0% | 17.8 | 719,227 | Common Stock |
| Marathon Digital Holdings Inc | Frederick G. Thiel | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.27 per share. | 31 Oct 2025 | 40,388 | 3,637,815 (46%) | 0% | 18.3 | 737,889 | Common Stock |
| Netflix | Reed Hastings | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Oct 2025 | 40,374 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Netflix | Reed Hastings | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 98.30 per share. | 31 Oct 2025 | 40,374 | 40,768 (0%) | 0% | 98.3 | 3,968,764 | Common Stock |
| Heico Corp (Class A) | Carlos L. Macau | EVP-CFO & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 38.37 per share. | 31 Oct 2025 | 40,000 | 175,338 (0%) | 0% | 38.4 | 1,534,976 | Class A Common Stock |
| Heico Corp (Class A) | Carlos L. Macau | EVP-CFO & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Oct 2025 | 40,000 | 57,656 | - | - | Option (Right to purchase Class A Common Stock) | |
| Portillos Inc Ordinary | Jill Waite | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2025 | 39,282 | 94,218 | - | 0 | Class A common stock | |
| Knowles Corp | Jeffrey S. Niew | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Oct 2025 | 38,404 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Knowles Corp | Jeffrey S. Niew | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 23.55 per share. | 31 Oct 2025 | 38,404 | 939,370 (1%) | 0% | 23.5 | 904,407 | Common Stock |
| Knowles Corp | Jeffrey S. Niew | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.07 per share. | 31 Oct 2025 | 38,404 | 977,774 (1%) | 0% | 16.1 | 617,152 | Common Stock |
| Clover Health Investments Corp (Class A) | Karen M. Soares | General Counsel & Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.53 per share. | 31 Oct 2025 | 38,086 | 1,236,228 | - | 3.5 | 134,444 | Class A Common Stock |
| Heico Corp (Class A) | Eric A. Mendelson | Director, Co-COB and Co-CEO, Member of 10% owner group | Payment of exercise price or tax liability using portion of securities received from the company at price $ 317.77 per share. | 31 Oct 2025 | 38,004 | 1,266,407 (2%) | 0% | 317.8 | 12,076,531 | Common Stock |
| Heico Corp (Class A) | Victor H. Mendelson | Director, Co-COB and Co-CEO, Member of 10% owner group | Payment of exercise price or tax liability using portion of securities received from the company at price $ 317.77 per share. | 31 Oct 2025 | 37,930 | 1,277,020 (2%) | 0% | 317.8 | 12,053,016 | Common Stock |
| Accuray Inc | Michael J. Murphy | VP, Corporate Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Oct 2025 | 37,500 | 112,500 | - | - | Restricted Stock Units | |
| Accuray Inc | Michael J. Murphy | VP, Corporate Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Oct 2025 | 37,500 | 37,500 (0%) | 0% | 0 | Common Stock | |
| Kiniksa Pharma Ltd (Class A) | John F. Paolini | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Oct 2025 | 36,542 | 0 | - | - | Share Option | |
| Kiniksa Pharma Ltd (Class A) | John F. Paolini | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.80 per share. | 31 Oct 2025 | 36,542 | 97,866 (0%) | 0% | 3.8 | 138,860 | Class A Ordinary Share |
| Portillos Inc Ordinary | Kelly M. Kaiser | General Counsel and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2025 | 35,514 | 104,375 | - | 0 | Class A common stock | |
| Heron Therapeutics Inc | Craig A. Collard | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Oct 2025 | 34,789 | 523,124 (0%) | 0% | - | Common Stock | |
| Heron Therapeutics Inc | Craig A. Collard | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Oct 2025 | 34,789 | 452,253 | - | - | Restricted Stock Units | |
| Ionis Pharma Inc | Richard S. Geary | EVP, Chief Development Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Oct 2025 | 34,664 | 16,443 | - | - | Non-Qualified Stock Option (right to buy) | |
| Ionis Pharma Inc | Richard S. Geary | EVP, Chief Development Officer | Sale of securities on an exchange or to another person at price $ 75.11 per share. | 31 Oct 2025 | 34,664 | 79,657 (0%) | 0% | 75.1 | 2,603,554 | Common Stock |
| Ionis Pharma Inc | Richard S. Geary | EVP, Chief Development Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 56.78 per share. | 31 Oct 2025 | 34,664 | 114,321 (0%) | 0% | 56.8 | 1,968,222 | Common Stock |
| Ionis Pharma Inc | Richard S. Geary | EVP, Chief Development Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Oct 2025 | 34,585 | 19,876 | - | - | Non-Qualified Stock Option (right to buy) | |
| Ionis Pharma Inc | Richard S. Geary | EVP, Chief Development Officer | Sale of securities on an exchange or to another person at price $ 75.11 per share. | 31 Oct 2025 | 34,585 | 79,657 (0%) | 0% | 75.1 | 2,597,621 | Common Stock |
| Ionis Pharma Inc | Richard S. Geary | EVP, Chief Development Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 60.89 per share. | 31 Oct 2025 | 34,585 | 114,242 (0%) | 0% | 60.9 | 2,105,881 | Common Stock |
| Marathon Digital Holdings Inc | Salman H. Khan | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.76 per share. | 31 Oct 2025 | 34,382 | 1,282,596 (16%) | 0% | 17.8 | 610,624 | Common Stock |
| Portillos Inc Ordinary | Keith Correia | Chief Information Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2025 | 33,177 | 62,616 | - | 0 | Class A common stock | |
| Hovnanian Enterprises Inc (Class A) | J. Larry Sorsby | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Oct 2025 | 32,331 | 0 | - | - | Performance Share Units (2022) | |
| Hovnanian Enterprises Inc (Class A) | J. Larry Sorsby | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Oct 2025 | 32,331 | 165,685 (3%) | 0% | 0 | Class A Common Stock | |
| Marathon Digital Holdings Inc | Salman H. Khan | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.27 per share. | 31 Oct 2025 | 30,946 | 1,251,650 (15%) | 0% | 18.3 | 565,383 | Common Stock |
| IZEA Worldwide Inc | Patrick J. Venetucci | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Oct 2025 | 30,650 | 216,850 (0%) | 0% | 0 | Common Stock | |
| Navan Inc Ordinary Shares | Sandesh Patnam | Director | 31 Oct 2025 | 30,537 | 30,537 | - | 21.2 | 648,911 | Class A Common Stock | |
| Navan Inc Ordinary Shares | Ariel M. Cohen | Director, Chairperson and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 25.00 per share. | 31 Oct 2025 | 30,333 | 763,653 | - | 25 | 758,325 | Class A Common Stock |
| Navan Inc Ordinary Shares | Ariel M. Cohen | Director, Chairperson and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 25.00 per share. | 31 Oct 2025 | 30,333 | 763,653 | - | 25 | 758,325 | Class A Common Stock |
| Navan Inc Ordinary Shares | Ariel M. Cohen | Director, Chairperson and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 25.00 per share. | 31 Oct 2025 | 30,333 | 763,653 | - | 25 | 758,325 | Class A Common Stock |
| AXT Inc | Morris S. Young | CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Oct 2025 | 30,000 | 2,519,490 (6%) | 0% | 0 | Common Stock | |
| Hovnanian Enterprises Inc (Class A) | J. Larry Sorsby | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Oct 2025 | 29,532 | 195,217 (3%) | 0% | 0 | Class A Common Stock | |
| Hovnanian Enterprises Inc (Class A) | J. Larry Sorsby | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Oct 2025 | 29,532 | 0 | - | - | Performance Share Units (2023) | |
| Clover Health Investments Corp (Class A) | Jamie L. Reynoso | CEO, Medicare Advantage | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.53 per share. | 31 Oct 2025 | 29,513 | 2,823,796 | - | 3.5 | 104,181 | Class A Common Stock |
| HCA Healthcare | Samuel N. Hazen | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 459.68 per share. | 31 Oct 2025 | 28,173 | 47,106 (0%) | 0% | 459.7 | 12,950,565 | Common Stock |
| Clover Health Investments Corp (Class A) | Conard Wai | CEO, Counterpart Health | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.53 per share. | 31 Oct 2025 | 27,930 | 1,150,085 | - | 3.5 | 98,593 | Class A Common Stock |
| ProPetro Holding Corp | G. Larry Lawrence | Director | Sale of securities on an exchange or to another person at price $ 10.84 per share. | 31 Oct 2025 | 27,000 | 35,831 (0%) | 0% | 10.8 | 292,680 | Common Stock |
| Bakkt Holdings Inc (Class A) | Karen Alexander | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2025 | 26,846 | 26,846 | - | - | Stock Option (right to buy) | |
| Ametek | Ronald J. Oscher | CHIEF ADMINISTRATIVE OFFICER | Sale of securities on an exchange or to another person at price $ 200.05 per share. | 31 Oct 2025 | 26,290 | 40,226 (0%) | 0% | 200.0 | 5,259,207 | Common Stock |
| Clover Health Investments Corp (Class A) | Brady Patrick Priest | CEO of Home Care | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.53 per share. | 31 Oct 2025 | 25,081 | 2,228,583 | - | 3.5 | 88,536 | Class A Common Stock |
| Snap Inc (Class A) | Michael J. O'Sullivan | General Counsel | Sale of securities on an exchange or to another person at price $ 7.73 per share. | 31 Oct 2025 | 24,000 | 490,454 (0%) | 0% | 7.7 | 185,623 | Class A Common Stock |
| Xcel Brands Inc | Robert W. D'Loren | Director, CEO and Chairman, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 1.26 per share. | 31 Oct 2025 | 23,505 | 524,739 (2%) | 0% | 1.3 | 29,616 | Common Stock |
| Midland States Bancorp Inc | Jeffrey S. Mefford | President | Grant, award, or other acquisition of securities at price $ 14.64 per share. | 31 Oct 2025 | 23,310 | 79,059 (0%) | 0% | 14.6 | 341,258 | Common Stock |
| Corning | Lewis A. Steverson | Vice Chairman, EVP and CLAO | Sale of securities on an exchange or to another person at price $ 89.05 per share. | 31 Oct 2025 | 23,142 | 17,575 (0%) | 0% | 89.0 | 2,060,765 | Common Stock |
| DuPont de Nemours | Erik T Hoover | SVP & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2025 | 23,079 | 112,101 (0%) | 0% | 0 | Common Stock | |
| Slide Insurance Holdings Inc | Bruce Lucas | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Oct 2025 | 22,918 | 229,182 | - | - | Common Stock | |
| Slide Insurance Holdings Inc | Bruce Lucas | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Oct 2025 | 22,918 | 1,158,572 | - | - | Common Stock | |
| Slide Insurance Holdings Inc | Bruce Lucas | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Oct 2025 | 22,918 | 322,817 | - | - | Restricted Stock Unit | |
| Slide Insurance Holdings Inc | Bruce Lucas | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Oct 2025 | 22,918 | 322,817 | - | - | Restricted Stock Unit | |
| Slide Insurance Holdings Inc | Shannon Lucas | Director, CRO & COO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Oct 2025 | 22,918 | 1,158,572 | - | - | Common Stock | |
| Slide Insurance Holdings Inc | Shannon Lucas | Director, CRO & COO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Oct 2025 | 22,918 | 322,817 | - | - | Restricted Stock Unit | |
| Slide Insurance Holdings Inc | Shannon Lucas | Director, CRO & COO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Oct 2025 | 22,918 | 322,817 | - | - | Restricted Stock Unit | |
| Slide Insurance Holdings Inc | Shannon Lucas | Director, CRO & COO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Oct 2025 | 22,918 | 229,182 | - | - | Common Stock | |
| StableX Tech Inc | Gregory T. Schiffman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2025 | 22,723 | 22,723 | - | - | Employee Stock Option (Right to Buy | |
| StableX Tech Inc | Wayne Walker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2025 | 22,723 | 22,723 | - | - | Employee Stock Option (Right to Buy | |
| StableX Tech Inc | Sebastian Giordano | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2025 | 22,723 | 22,723 | - | - | Employee Stock Option (Right to Buy | |
| StableX Tech Inc | Zvi Joseph | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2025 | 22,723 | 22,723 | - | - | Employee Stock Option (Right to Buy | |
| Allbirds Inc (Class A) | Lily Yan Hughes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2025 | 22,222 | 22,222 | - | 0 | Class A Common Stock | |
| Amazon | Douglas J. Herrington | CEO Worldwide Amazon Stores | Sale of securities on an exchange or to another person at price $ 250.03 per share. | 31 Oct 2025 | 22,000 | 493,507 (0%) | 0% | 250.0 | 5,500,660 | Common Stock, par value $.01 per share |
| Natera Inc | Herm Rosenman | Director | Sale of securities on an exchange or to another person at price $ 227.35 per share. | 31 Oct 2025 | 21,910 | 32,479 (0%) | 0% | 227.4 | 4,981,309 | Common Stock |
| Rithm Cap Corp | Michael Nierenberg | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2025 | 21,495 | 966,433 | - | - | Class B Profits Units of Rithm Capital Management LLC | |
| Hovnanian Enterprises Inc (Class A) | J. Larry Sorsby | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Oct 2025 | 21,200 | 0 | - | - | Performance Share Units (2021) | |
| Hovnanian Enterprises Inc (Class A) | J. Larry Sorsby | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Oct 2025 | 21,200 | 216,417 (3%) | 0% | 0 | Class A Common Stock | |
| Corning | Edward A. Schlesinger | Exec. Vice President and CFO | Sale of securities on an exchange or to another person at price $ 91.25 per share. | 31 Oct 2025 | 20,893 | 66,959 (0%) | 0% | 91.2 | 1,906,486 | Common Stock |
| Iridium Comm Inc | Thomas J. Fitzpatrick | Director | Sale of securities on an exchange or to another person at price $ 18.00 per share. | 31 Oct 2025 | 20,839 | 231,034 (0%) | 0% | 18 | 375,102 | Common Stock |
| DuPont de Nemours | Antonella B. Franzen | SVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2025 | 20,755 | 52,622 (0%) | 0% | 0 | Common Stock | |
| Strata Critical Medical Inc (Class A) | Amir M. Cohen | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.03 per share. | 31 Oct 2025 | 20,497 | 121,342 | - | 5.0 | 103,100 | Class A common stock, $0.0001 par value per share |
| Bristow Grp Inc | Alan Corbett | COO, Government Services | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Oct 2025 | 20,185 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Bristow Grp Inc | Alan Corbett | COO, Government Services | Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.01 per share. | 31 Oct 2025 | 20,185 | 105,808 | - | 14.0 | 282,792 | Common Stock |
| Kimberly-Clark | Tamera Fenske | Chief Supply Chain Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2025 | 20,176 | 26,343 (0%) | 0% | 0 | Common Stock | |
| Ionis Pharma Inc | Richard S. Geary | EVP, Chief Development Officer | Sale of securities on an exchange or to another person at price $ 75.11 per share. | 31 Oct 2025 | 20,000 | 59,657 (0%) | 0% | 75.1 | 1,502,166 | Common Stock |
| MGIC Investment Corp | Paula C. Maggio | EVP and General Counsel | Sale of securities on an exchange or to another person at price $ 27.44 per share. | 31 Oct 2025 | 20,000 | 117,394 (0%) | 0% | 27.4 | 548,820 | Common Stock |
| DuPont de Nemours | Christopher Raia | Senior Vice President & CHRO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2025 | 19,232 | 82,808 (0%) | 0% | 0 | Common Stock | |
| Bristow Grp Inc | Alan Corbett | COO, Government Services | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.70 per share. | 31 Oct 2025 | 19,202 | 73,304 | - | 40.7 | 781,521 | Common Stock |
| Heico Corp (Class A) | Carlos L. Macau | EVP-CFO & Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 247.73 per share. | 31 Oct 2025 | 19,022 | 156,316 (0%) | 0% | 247.7 | 4,712,320 | Class A Common Stock |
| F5 | Thomas Dean Fountain | EVP Global Services & Strategy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2025 | 18,896 | 39,595 (0%) | 0% | 0 | Common Stock | |
| Mama`s Creations Inc | Adam L. Michaels | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2025 | 18,885 | 614,033 | - | 0 | Common Stock | |
| Travere Therapeutics Inc | Timothy P. Coughlin | Director | Sale of securities on an exchange or to another person at price $ 35.03 per share. | 31 Oct 2025 | 18,000 | 55,500 (0%) | 0% | 35.0 | 630,601 | Common Stock |
| Fox Corp (Class A) | Paul D. Ryan | Director | Sale of securities on an exchange or to another person at price $ 64.36 per share. | 31 Oct 2025 | 17,767 | 0 (0%) | 0% | 64.4 | 1,143,484 | Class A Common Stock |
| TELA Bio Inc | William Plovanic | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2025 | 17,550 | 17,550 | - | - | Stock Option (Right to Buy) | |
| Mannkind Corp | Sanjay R. Singh | EVP Technical Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.59 per share. | 31 Oct 2025 | 17,071 | 473,988 (0%) | 0% | 5.6 | 95,427 | Common Stock, $0.01 Par Value |
| Navan Inc Ordinary Shares | Benjamin A. Horowitz | Director, Ten Percent Owner | 31 Oct 2025 | 17,001 | 17,001 | - | - | Class A Common Stock | ||
| Limoneira Co | Harold S. Edwards | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.13 per share. | 31 Oct 2025 | 16,798 | 208,492 (1%) | 0% | 14.1 | 237,356 | Common Stock |
| F5 | Chad Whalen | EVP, Worldwide Sales | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2025 | 16,325 | 39,916 (0%) | 0% | 0 | Common Stock | |
| Ionis Pharma Inc | Joseph Loscalzo | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 52.22 per share. | 31 Oct 2025 | 16,000 | 52,330 (0%) | 0% | 52.2 | 835,520 | Common Stock |
| Ionis Pharma Inc | Joseph Loscalzo | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Oct 2025 | 16,000 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Ionis Pharma Inc | Joseph Loscalzo | Director | Sale of securities on an exchange or to another person at price $ 75.10 per share. | 31 Oct 2025 | 16,000 | 36,330 (0%) | 0% | 75.1 | 1,201,669 | Common Stock |
| AMEX | Elizabeth Rutledge | Chief Marketing Officer | Sale of securities on an exchange or to another person at price $ 360.09 per share. | 31 Oct 2025 | 15,532 | 109,756 (0%) | 0% | 360.1 | 5,592,918 | Common Stock |
| Roku Inc (Class A) | Charles Collier | President, Roku Media | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Oct 2025 | 15,404 | 498,042 | - | - | Employee Stock Option (right to buy) | |
| Roku Inc (Class A) | Charles Collier | President, Roku Media | Exercise or conversion of derivative security received from the company (such as an option) at price $ 49.59 per share. | 31 Oct 2025 | 15,404 | 15,604 (0%) | 0% | 49.6 | 763,884 | Class A Common Stock |
| AMEX | Elizabeth Rutledge | Chief Marketing Officer | Sale of securities on an exchange or to another person at price $ 360.79 per share. | 31 Oct 2025 | 15,196 | 94,560 (0%) | 0% | 360.8 | 5,482,565 | Common Stock |
| Midland States Bancorp Inc | Eric T. Lemke | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 14.64 per share. | 31 Oct 2025 | 14,940 | 43,333 (0%) | 0% | 14.6 | 218,722 | Common Stock |
| Carvana Co. (Class A) | Ryan Keeton | Chief Brand Officer | Sale of securities on an exchange or to another person at price $ 301.34 per share. | 31 Oct 2025 | 14,512 | 123,625 (0%) | 0% | 301.3 | 4,373,046 | Class A Common Stock |
| Natera Inc | Herm Rosenman | Director | Sale of securities on an exchange or to another person at price $ 226.62 per share. | 31 Oct 2025 | 14,372 | 54,389 (0%) | 0% | 226.6 | 3,256,945 | Common Stock |
| Ametek | Ronald J. Oscher | CHIEF ADMINISTRATIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 63.37 per share. | 31 Oct 2025 | 14,310 | 54,536 (0%) | 0% | 63.4 | 906,825 | Common Stock |
| Ametek | Ronald J. Oscher | CHIEF ADMINISTRATIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Oct 2025 | 14,310 | 0 | - | - | Stock Option | |
| Marathon Digital Holdings Inc | Zabi Nowaid | General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.76 per share. | 31 Oct 2025 | 13,753 | 767,357 (9%) | 0% | 17.8 | 244,253 | Common Stock |
| Conduent Inc | Michael J. Fucci | Director | Grant, award, or other acquisition of securities at price $ 2.36 per share. | 31 Oct 2025 | 13,419 | 13,419 (0%) | 0% | 2.4 | 31,669 | Common Stock |
| Bristow Grp Inc | Alan Corbett | COO, Government Services | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.70 per share. | 31 Oct 2025 | 13,302 | 92,506 | - | 40.7 | 541,391 | Common Stock |
| Carvana Co. (Class A) | Ryan Keeton | Chief Brand Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 44.21 per share. | 31 Oct 2025 | 13,190 | 147,826 (0%) | 0% | 44.2 | 583,130 | Class A Common Stock |
| Carvana Co. (Class A) | Ryan Keeton | Chief Brand Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Oct 2025 | 13,190 | 0 | - | - | Stock Options (Right to Buy) | |
| Hovnanian Enterprises Inc (Class A) | Ara K. Hovnanian | Director, Chairman of Bd., Pres. & CEO, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 31 Oct 2025 | 13,100 | 278,814 | - | - | Class B Common Stock | |
| DuPont de Nemours | Steven P Larrabee | SVP & CIO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2025 | 13,078 | 51,747 (0%) | 0% | 0 | Common Stock | |
| Ares Cap Corp | Kort Schnabel | Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 20.39 per share. | 31 Oct 2025 | 13,000 | 28,000 (0%) | 0% | 20.4 | 265,070 | Common Stock |
| Castle Biosciences Inc | Kristen M. Oelschlager | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 25.04 per share. | 31 Oct 2025 | 12,678 | 27,569 (0%) | 0% | 25.0 | 317,457 | Common Stock |
| Chipotle Mexican Grill | Matthew R. Bush | Controller, PAO | Grant, award, or other acquisition of securities at price $ 31.69 per share. | 31 Oct 2025 | 12,623 | 16,933 (0%) | 0% | 31.7 | 400,023 | common stock |
| Insight Molecular Diagnostics Inc | Andrea James | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.01 per share. | 31 Oct 2025 | 12,175 | 189,056 (0%) | 0% | 6.0 | 73,172 | Common Stock |
| Accuray Inc | Michael J. Murphy | VP, Corporate Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.41 per share. | 31 Oct 2025 | 12,001 | 25,499 (0%) | 0% | 1.4 | 16,921 | Common Stock |
| Natera Inc | Herm Rosenman | Director | Sale of securities on an exchange or to another person at price $ 228.49 per share. | 31 Oct 2025 | 11,987 | 20,492 (0%) | 0% | 228.5 | 2,738,859 | Common Stock |
| Ametek | Ronald J. Oscher | CHIEF ADMINISTRATIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Oct 2025 | 11,980 | 0 | - | - | Stock Option | |
| Ametek | Ronald J. Oscher | CHIEF ADMINISTRATIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 85.45 per share. | 31 Oct 2025 | 11,980 | 66,516 (0%) | 0% | 85.5 | 1,023,691 | Common Stock |
| TELA Bio Inc | William Plovanic | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2025 | 11,925 | 11,925 (0%) | 0% | 0 | Common Stock | |
| MetLife | Adrienne Karen O’Neill | EVP & Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2025 | 11,902 | 11,902 (0%) | 0% | - | Common Stock | |
| Pitney Bowes Inc | Peter C. Brimm | Director | Purchase of securities on an exchange or from another person at price $ 10.16 per share. | 31 Oct 2025 | 11,800 | 11,800 (0%) | 0% | 10.2 | 119,888 | Common Stock |
| Heron Therapeutics Inc | William P. Forbes | EVP, Chief Development Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Oct 2025 | 11,694 | 152,027 | - | - | Restricted Stock Units | |
| Heron Therapeutics Inc | William P. Forbes | EVP, Chief Development Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Oct 2025 | 11,694 | 166,203 (0%) | 0% | - | Common Stock | |
| Heron Therapeutics Inc | Ira Duarte | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Oct 2025 | 11,694 | 152,027 | - | - | Restricted Stock Units | |
| Heron Therapeutics Inc | Ira Duarte | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Oct 2025 | 11,694 | 179,786 (0%) | 0% | - | Common Stock | |
| IZEA Worldwide Inc | Peter J. Biere | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2025 | 11,495 | 11,495 | - | - | Restricted Stock Units | |
| Washington Federal Inc | Cathy E. Cooper | EVP & Chief Consumer Banker | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Oct 2025 | 11,296 | 81,125 (0%) | 0% | 0 | Common Stock | |
| Washington Federal Inc | Kim E. Robison | EVP & Chief Operations Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Oct 2025 | 11,296 | 118,499 (0%) | 0% | 0 | Common Stock | |
| Washington Federal Inc | Ryan M. Mauer | EVP & Chief Credit Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Oct 2025 | 11,296 | 108,113 (0%) | 0% | 0 | Common Stock | |
| Xcel Brands Inc | Robert W. D'Loren | Director, CEO and Chairman, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.26 per share. | 31 Oct 2025 | 10,859 | 513,880 (2%) | 0% | 1.3 | 13,682 | Common Stock |
| AMEX | Stephen J. Squeri | Director, Chairman and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Oct 2025 | 10,688 | 163,292 (0%) | 0% | 0 | Common Stock | |
| Washington Federal Inc | Kelli J. Holz | EVP & CFO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Oct 2025 | 10,630 | 95,508 (0%) | 0% | 0 | Common Stock | |
| IZEA Worldwide Inc | Patrick J. Venetucci | Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.15 per share. | 31 Oct 2025 | 10,419 | 206,431 (0%) | 0% | 5.2 | 53,658 | Common Stock |
| Huron Consulting Grp Inc | C. Mark Hussey | Director, CEO and President | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Oct 2025 | 10,170 | 70,948 (0%) | 0% | 0 | Common Stock | |
| Enphase Energy | Badri Kothandaraman | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 30.93 per share. | 31 Oct 2025 | 10,000 | 1,630,632 (1%) | 0% | 30.9 | 309,317 | Common Stock |
| Grid Dynamics Holdings Inc (Class A) | Leonard Livschitz | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 9.00 per share. | 31 Oct 2025 | 10,000 | 2,851,378 | - | 9 | 90,000 | Common Stock |
| Snowflake Inc (Class A) | Christian Kleinerman | EVP, Product Management | Sale of securities on an exchange or to another person at price $ 277.73 per share. | 31 Oct 2025 | 10,000 | 522,450 | - | 277.7 | 2,777,300 | Common Stock |
| Travere Therapeutics Inc | Timothy P. Coughlin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.44 per share. | 31 Oct 2025 | 10,000 | 73,500 (0%) | 0% | 17.4 | 174,400 | Common Stock |
| Travere Therapeutics Inc | Timothy P. Coughlin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Oct 2025 | 10,000 | 0 | - | - | Director stock option (right to buy) | |
| Vestand Inc (Class A) | James Chae | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.51 per share. | 31 Oct 2025 | 10,000 | 2,463,798 | - | 0.5 | 5,103 | Class A common stock, $0.0001 par value |
| Vestand Inc (Class A) | James Chae | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.51 per share. | 31 Oct 2025 | 10,000 | 2,413,798 | - | 0.5 | 5,065 | Class A common stock, $0.0001 par value |
| Allspring Global Dividend Opportunity Fund | Christopher M. Lee | Portfolio Manager | Purchase of securities on an exchange or from another person at price $ 4.68 per share. | 31 Oct 2025 | 9,990 | 32,000 (0%) | 0% | 4.7 | 46,752 | Common Shares |
| Marathon Digital Holdings Inc | Zabi Nowaid | General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.27 per share. | 31 Oct 2025 | 9,981 | 757,376 (9%) | 0% | 18.3 | 182,353 | Common Stock |
| Limoneira Co | Mark Palamountain | EVP, CFO and Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.13 per share. | 31 Oct 2025 | 9,970 | 90,313 (0%) | 0% | 14.1 | 140,876 | Common Stock |
| Limoneira Co | Harold S. Edwards | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.13 per share. | 31 Oct 2025 | 9,811 | 215,479 (1%) | 0% | 14.1 | 138,629 | Common Stock |
| Carvana Co. (Class A) | Ryan Keeton | Chief Brand Officer | Sale of securities on an exchange or to another person at price $ 300.38 per share. | 31 Oct 2025 | 9,689 | 138,137 (0%) | 0% | 300.4 | 2,910,382 | Class A Common Stock |
| Washington Federal Inc | Brent J. Beardall | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 29.03 per share. | 31 Oct 2025 | 9,652 | 290,212 (0%) | 0% | 29.0 | 280,198 | Common Stock |
| Plug Power Inc | Andrew J. Marsh | Director, CEO | Grant, award, or other acquisition of securities at price $ 2.69 per share. | 31 Oct 2025 | 9,415 | 918,343 (0%) | 0% | 2.7 | 25,326 | Common Stock |
| Navan Inc Ordinary Shares | Benjamin A. Horowitz | Director, Ten Percent Owner | 31 Oct 2025 | 9,274 | 0 | - | - | Series F Preferred Stock | ||
| AllianceBernstein National Municipal Income Fund Inc | Garry L. Moody | Director | Purchase of securities on an exchange or from another person at price $ 11.08 per share. | 31 Oct 2025 | 9,000 | 9,000 (0%) | 0% | 11.1 | 99,720 | Common Stock |
| Kimberly-Clark | Tamera Fenske | Chief Supply Chain Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 119.71 per share. | 31 Oct 2025 | 8,987 | 19,842 (0%) | 0% | 119.7 | 1,075,834 | Common Stock |
| AMEX | Elizabeth Rutledge | Chief Marketing Officer | Sale of securities on an exchange or to another person at price $ 361.57 per share. | 31 Oct 2025 | 8,984 | 85,576 (0%) | 0% | 361.6 | 3,248,345 | Common Stock |
| Jabil | May Yee Yap | SVP, Chief Information Officer | Sale of securities on an exchange or to another person at price $ 225.03 per share. | 31 Oct 2025 | 8,858 | 25,421 (0%) | 0% | 225.0 | 1,993,316 | Common Stock |
| Corning | Edward A. Schlesinger | Exec. Vice President and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 33.92 per share. | 31 Oct 2025 | 8,844 | 87,852 (0%) | 0% | 33.9 | 299,988 | Common Stock |
| Corning | Edward A. Schlesinger | Exec. Vice President and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Oct 2025 | 8,844 | 0 | - | - | Stock Options (Right to Buy) | |
| Cencora | Pawan Verma | EVP, Chief Data & Info Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Oct 2025 | 8,537 | 0 | - | - | Restricted Stock Units | |
| Cencora | Pawan Verma | EVP, Chief Data & Info Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 337.81 per share. | 31 Oct 2025 | 8,537 | 8,551 (0%) | 0% | 337.8 | 2,883,884 | Common Stock |
| Techprecision Corp | Andrew A. Levy | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Oct 2025 | 8,300 | 386,618 | - | 0 | Common Stock | |
| Amazon | Jonathan J. Rubinstein | Director | Sale of securities on an exchange or to another person at price $ 250.03 per share. | 31 Oct 2025 | 8,173 | 80,030 (0%) | 0% | 250.0 | 2,043,495 | Common Stock, par value $.01 per share |
| TKO (Class A) | Dwayne Johnson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Oct 2025 | 8,046 | 370,138 | - | 0 | Class A Common Stock | |
| TKO (Class A) | Dwayne Johnson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Oct 2025 | 8,046 | 16,093 | - | - | Restricted Stock Unit | |
| Capitol Federal Fin | Jackson C Rick | Executive Vice President | Purchase of securities on an exchange or from another person at price $ 6.05 per share. | 31 Oct 2025 | 8,000 | 156,752 (0%) | 0% | 6.0 | 48,399 | CFFN common stock |
| iRhythm Tech Inc | Daniel G. Wilson | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 207.44 per share. | 31 Oct 2025 | 8,000 | 26,470 (0%) | 0% | 207.4 | 1,659,520 | Common Stock |
| Travere Therapeutics Inc | Timothy P. Coughlin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.33 per share. | 31 Oct 2025 | 8,000 | 63,500 (0%) | 0% | 16.3 | 130,640 | Common Stock |
| Travere Therapeutics Inc | Timothy P. Coughlin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Oct 2025 | 8,000 | 0 | - | - | Director stock option (right to buy) | |
| Immersion Corp | William C. Martin | Director, Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2025 | 7,952 | 1,367,992 (4%) | 0% | 0 | Common Stock | |
| Conmed Corp | Todd W. Garner | Executive Vice President & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Oct 2025 | 7,500 | 15,227 | - | - | RSUs (Restricted Stock Units) | |
| Conmed Corp | Todd W. Garner | Executive Vice President & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Oct 2025 | 7,500 | 7,500 (0%) | 0% | 0 | Common Stock | |
| Netflix | Reed Hastings | Director | Sale of securities on an exchange or to another person at price $ 1119.41 per share. | 31 Oct 2025 | 7,426 | 25,067 (0%) | 0% | 1119.4 | 8,312,751 | Common Stock |
| Netgear Inc | Pramod Badjate | President & GM, NFB | Payment of exercise price or tax liability using portion of securities received from the company at price $ 34.72 per share. | 31 Oct 2025 | 7,404 | 159,361 (0%) | 0% | 34.7 | 257,067 | Common Stock |
| Iron Mountain | Mark Kidd | EVP, GM Data Centers & ALM | Sale of securities on an exchange or to another person at price $ 100.82 per share. | 31 Oct 2025 | 7,306 | 73,081 (0%) | 0% | 100.8 | 736,591 | Common Stock, par value $.01 per share |
| Iron Mountain | Mark Kidd | EVP, GM Data Centers & ALM | Exercise or conversion of derivative security received from the company (such as an option) at price $ 31.46 per share. | 31 Oct 2025 | 7,306 | 80,387 (0%) | 0% | 31.5 | 229,847 | Common Stock, par value $.01 per share |
| Iron Mountain | Mark Kidd | EVP, GM Data Centers & ALM | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Oct 2025 | 7,306 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Labcorp | Richelle P. Parham | Director | Sale of securities on an exchange or to another person at price $ 254.28 per share. | 31 Oct 2025 | 7,009 | 2,469 (0%) | 0% | 254.3 | 1,782,273 | Common Stock |
| Silgan Holdings Inc | Adam J. Greenlee | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 38.19 per share. | 31 Oct 2025 | 7,000 | 328,164 (0%) | 0% | 38.2 | 267,298 | Common Stock |
| IZEA Worldwide Inc | Peter J. Biere | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Oct 2025 | 6,948 | 13,897 | - | - | Restricted Stock Units | |
| IZEA Worldwide Inc | Peter J. Biere | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Oct 2025 | 6,948 | 79,498 (0%) | 0% | 0 | Common Stock | |
| First US Bancshares Inc | William Christopher Mitchell | SEVP-Consumer Lending-Bank | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Oct 2025 | 6,800 | 0 | - | - | Common Stock, $.01 par value | |
| First US Bancshares Inc | William Christopher Mitchell | SEVP-Consumer Lending-Bank | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.30 per share. | 31 Oct 2025 | 6,800 | 26,876 (0%) | 0% | 8.3 | 56,440 | Common Stock, $.01 par value |
| Wyndham Hotels & Resorts Inc | Michele Allen | CFO & Head of Strategy | Payment of exercise price or tax liability using portion of securities received from the company at price $ 73.43 per share. | 31 Oct 2025 | 6,737 | 32,859 (0%) | 0% | 73.4 | 494,698 | Common Stock |
| Pacira BioSciences Inc | Shawn M. Cross | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.38 per share. | 31 Oct 2025 | 6,690 | 68,310 (0%) | 0% | 21.4 | 143,032 | Common Stock |
| Dorman Products Inc | David M. Hession | SVP and CFO | Sale of securities on an exchange or to another person at price $ 135.42 per share. | 31 Oct 2025 | 6,515 | 8,496 (0%) | 0% | 135.4 | 882,229 | Common Stock |
| DuPont de Nemours | Steven P Larrabee | SVP & CIO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 34.12 per share. | 31 Oct 2025 | 6,384 | 45,363 (0%) | 0% | 34.1 | 217,822 | Common Stock |
| Commercial Metals Co. | Brian N. Halloran | SVP, N. America Steel Group | Sale of securities on an exchange or to another person at price $ 59.87 per share. | 31 Oct 2025 | 6,232 | 58,055 (0%) | 0% | 59.9 | 373,110 | Common Stock |
| Designer Brands Inc (Class A) | Joseph A. Schottenstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2025 | 6,098 | 285,093 (0%) | 0% | 0 | Class A Common Shares | |
| Vestand Inc (Class A) | James Chae | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.76 per share. | 31 Oct 2025 | 6,000 | 2,483,506 | - | 0.8 | 4,576 | Class A common stock, $0.0001 par value |
| Rithm Cap Corp | Michael Nierenberg | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2025 | 5,988 | 269,258 | - | - | Class B Profits Units of Rithm Capital Management LLC | |
| Atlas Lithium Corp | Igor Tkachenko | VP, Corporate Strategy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2025 | 5,922 | 254,597 | - | 0 | Common Stock | |
| Lattice Semiconductor Corp | Tonya Stevens | CVP, Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 72.96 per share. | 31 Oct 2025 | 5,913 | 77,849 (0%) | 0% | 73.0 | 431,412 | Common Stock |
| Logitech Intl S.A. | Neela Montgomery | Director | Sale of securities on an exchange or to another person at price $ 120.61 per share. | 31 Oct 2025 | 5,833 | 12,781 (0%) | 0% | 120.6 | 703,520 | Registered Shares |
| Limoneira Co | Mark Palamountain | EVP, CFO and Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.13 per share. | 31 Oct 2025 | 5,822 | 94,461 (0%) | 0% | 14.1 | 82,265 | Common Stock |
| UMB Fin Corp | J. Mariner Kemper | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2025 | 5,613 | 329,479 (0%) | 0% | 0 | Common Stock | |
| Travere Therapeutics Inc | Peter Heerma | CHIEF COMMERCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 35.00 per share. | 31 Oct 2025 | 5,591 | 119,071 (0%) | 0% | 35 | 195,685 | Common Stock |
| American Tower | Eugene Frederick Reilly | Director | Purchase of securities on an exchange or from another person at price $ 178.99 per share. | 31 Oct 2025 | 5,554 | 5,689 (0%) | 0% | 179.0 | 994,110 | Common Stock |
| Hovnanian Enterprises Inc (Class A) | J. Larry Sorsby | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 120.23 per share. | 31 Oct 2025 | 5,525 | 126,580 (2%) | 0% | 120.2 | 664,271 | Class A Common Stock |
| Hovnanian Enterprises Inc (Class A) | J. Larry Sorsby | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 120.23 per share. | 31 Oct 2025 | 5,525 | 133,354 (2%) | 0% | 120.2 | 664,271 | Class A Common Stock |
| ITT Inc | Emmanuel Caprais | Senior Vice President & CFO | Sale of securities on an exchange or to another person at price $ 185.23 per share. | 31 Oct 2025 | 5,500 | 36,830 (0%) | 0% | 185.2 | 1,018,760 | Common Stock |
| Fennec Pharma Inc | Rostislav Raykov | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2025 | 5,208 | 92,318 (0%) | 0% | 0 | Common shares | |
| Washington Federal Inc | Brent J. Beardall | Director, President & CEO | Other type of transaction at price $ 29.03 per share. | 31 Oct 2025 | 5,204 | 285,008 (0%) | 0% | 29.0 | 151,072 | Common Stock |
| First US Bancshares Inc | William Christopher Mitchell | SEVP-Consumer Lending-Bank | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.06 per share. | 31 Oct 2025 | 5,049 | 21,827 (0%) | 0% | 13.1 | 65,940 | Common Stock, $.01 par value |
| NexPoint Residential Trust Inc | Brian Mitts | Director | Sale of securities on an exchange or to another person at price $ 30.52 per share. | 31 Oct 2025 | 5,000 | 60,900 (0%) | 0% | 30.5 | 152,600 | Common Stock |
| Snowflake Inc (Class A) | Christian Kleinerman | EVP, Product Management | Sale of securities on an exchange or to another person at price $ 275.00 per share. | 31 Oct 2025 | 5,000 | 38,568 | - | 275 | 1,375,000 | Common Stock |
| Vestand Inc (Class A) | James Chae | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.51 per share. | 31 Oct 2025 | 5,000 | 2,408,798 | - | 0.5 | 2,539 | Class A common stock, $0.0001 par value |
| Vestand Inc (Class A) | James Chae | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.89 per share. | 31 Oct 2025 | 5,000 | 2,489,506 | - | 0.9 | 4,466 | Class A common stock, $0.0001 par value |
| Vestand Inc (Class A) | James Chae | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.65 per share. | 31 Oct 2025 | 5,000 | 2,475,506 | - | 0.7 | 3,263 | Class A common stock, $0.0001 par value |
| Vestand Inc (Class A) | James Chae | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.52 per share. | 31 Oct 2025 | 5,000 | 2,458,798 | - | 0.5 | 2,618 | Class A common stock, $0.0001 par value |
| Vestand Inc (Class A) | James Chae | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.52 per share. | 31 Oct 2025 | 5,000 | 2,453,798 | - | 0.5 | 2,605 | Class A common stock, $0.0001 par value |
| Vestand Inc (Class A) | James Chae | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.51 per share. | 31 Oct 2025 | 5,000 | 2,448,798 | - | 0.5 | 2,551 | Class A common stock, $0.0001 par value |
| Vestand Inc (Class A) | James Chae | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.51 per share. | 31 Oct 2025 | 5,000 | 2,443,798 | - | 0.5 | 2,528 | Class A common stock, $0.0001 par value |
| Vestand Inc (Class A) | James Chae | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.52 per share. | 31 Oct 2025 | 5,000 | 2,438,798 | - | 0.5 | 2,592 | Class A common stock, $0.0001 par value |
| Vestand Inc (Class A) | James Chae | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.51 per share. | 31 Oct 2025 | 5,000 | 2,433,798 | - | 0.5 | 2,553 | Class A common stock, $0.0001 par value |
| Vestand Inc (Class A) | James Chae | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.51 per share. | 31 Oct 2025 | 5,000 | 2,428,798 | - | 0.5 | 2,553 | Class A common stock, $0.0001 par value |
| Vestand Inc (Class A) | James Chae | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.51 per share. | 31 Oct 2025 | 5,000 | 2,423,798 | - | 0.5 | 2,530 | Class A common stock, $0.0001 par value |
| AMEX | Elizabeth Rutledge | Chief Marketing Officer | Sale of securities on an exchange or to another person at price $ 358.10 per share. | 31 Oct 2025 | 4,971 | 129,522 (0%) | 0% | 358.1 | 1,780,115 | Common Stock |
| Navan Inc Ordinary Shares | Ariel M. Cohen | Director, Chairperson and CEO, Ten Percent Owner | 31 Oct 2025 | 4,796 | 4,796 | - | - | Class B Common Stock | ||
| Navan Inc Ordinary Shares | Ariel M. Cohen | Director, Chairperson and CEO, Ten Percent Owner | 31 Oct 2025 | 4,796 | 0 | - | 0 | Class A Common Stock | ||
| Navan Inc Ordinary Shares | Ariel M. Cohen | Director, Chairperson and CEO, Ten Percent Owner | 31 Oct 2025 | 4,796 | 0 | - | 0 | Class A Common Stock | ||
| Navan Inc Ordinary Shares | Ariel M. Cohen | Director, Chairperson and CEO, Ten Percent Owner | 31 Oct 2025 | 4,796 | 0 | - | 0 | Class A Common Stock | ||
| Navan Inc Ordinary Shares | Ariel M. Cohen | Director, Chairperson and CEO, Ten Percent Owner | 31 Oct 2025 | 4,796 | 4,796 | - | - | Class B Common Stock | ||
| Navan Inc Ordinary Shares | Ariel M. Cohen | Director, Chairperson and CEO, Ten Percent Owner | 31 Oct 2025 | 4,796 | 4,796 | - | - | Class B Common Stock | ||
| Rithm Cap Corp | Michael Nierenberg | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2025 | 4,776 | 315,384 | - | - | Class B Profits Units of Rithm Capital Management LLC | |
| Roku Inc (Class A) | Charles Collier | President, Roku Media | Sale of securities on an exchange or to another person at price $ 105.18 per share. | 31 Oct 2025 | 4,735 | 600 (0%) | 0% | 105.2 | 498,027 | Class A Common Stock |
| Carvana Co. (Class A) | Ryan Keeton | Chief Brand Officer | Sale of securities on an exchange or to another person at price $ 303.17 per share. | 31 Oct 2025 | 4,732 | 118,893 (0%) | 0% | 303.2 | 1,434,600 | Class A Common Stock |
| IZEA Worldwide Inc | Peter J. Biere | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.15 per share. | 31 Oct 2025 | 4,713 | 74,785 (0%) | 0% | 5.2 | 24,272 | Common Stock |
| Navan Inc Ordinary Shares | Sandesh Patnam | Director | 31 Oct 2025 | 4,708 | 35,245 | - | 0.0 | 141 | Class A Common Stock | |
| Navan Inc Ordinary Shares | Sandesh Patnam | Director | 31 Oct 2025 | 4,708 | 0 | - | - | Warrant (Right to Buy) | ||
| Harley-Davidson Inc | Charles Do | Sr. Vice President, HDFSI | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Oct 2025 | 4,655 | 4,656 | - | - | Restricted Stock Units | |
| Harley-Davidson Inc | Charles Do | Sr. Vice President, HDFSI | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Oct 2025 | 4,655 | 5,802 (0%) | 0% | 0 | Common Stock | |
| CPI Card Group Inc | Ernesto Boada | Chief Information Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Oct 2025 | 4,653 | 4,653 (0%) | 0% | - | Common Stock | |
| CPI Card Group Inc | Ernesto Boada | Chief Information Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Oct 2025 | 4,653 | 9,300 | - | - | Restricted Stock Units | |
| AllianceBernstein National Municipal Income Fund Inc | Garry L. Moody | Director | Purchase of securities on an exchange or from another person at price $ 11.06 per share. | 31 Oct 2025 | 4,500 | 13,500 (0%) | 0% | 11.1 | 49,787 | Common Stock |
| Kimberly-Clark | Tamera Fenske | Chief Supply Chain Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Oct 2025 | 4,483 | 0 | - | - | Restricted Share Units 10/31/2022(w/Dividends reinvested) | |
| Kimberly-Clark | Tamera Fenske | Chief Supply Chain Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Oct 2025 | 4,483 | 30,826 (0%) | 0% | 0 | Common Stock | |
| MetLife | Monica M. Curtis | EVP & Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 79.82 per share. | 31 Oct 2025 | 4,420 | 10,452 (0%) | 0% | 79.8 | 352,804 | Common Stock |
| Rithm Cap Corp | Michael Nierenberg | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2025 | 4,408 | 999,147 (0%) | 0% | 0 | Common Stock | |
| Cencora | Pawan Verma | EVP, Chief Data & Info Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 337.81 per share. | 31 Oct 2025 | 4,367 | 4,184 (0%) | 0% | 337.8 | 1,475,216 | Common Stock |
This section tracks all disclosures required by the U.S. Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, particularly those related to Section 16 and Rule 10b-5, which govern insider trading activities in the U.S. market. These disclosures are made by corporate insiders, including executives, officers, directors, significant employees, and large shareholders, who are buying and selling stock in their own companies. You can search and filter within these results. You can also sort the information by clicking on the column headers.